Peking University People's Hospital
Clinical trials sponsored by Peking University People's Hospital, explained in plain language.
-
Timing is everything: new trial tests when to give extra immune cells after transplant to fight leukemia relapse
Disease control Not yet recruitingThis study aims to find the best timing for giving extra donor immune cells to patients who have received a stem cell transplant for hard-to-treat blood cancers like leukemia. It will compare giving these cells as a preventive measure versus waiting and giving them only if early …
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New breathing technique aims to save lives after major chest trauma
Disease control Not yet recruitingThis study is testing a special breathing therapy for people with severe chest injuries from accidents like car crashes. The therapy uses a non-invasive monitor to guide gentle lung expansion and oscillation techniques, aiming to help clear mucus and improve breathing. Researcher…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope to stop blood Cancer's return after transplant
Disease control Not yet recruitingThis study is testing whether a drug called interferon-α can help prevent cancer from coming back in patients with high-risk forms of leukemia or myelodysplastic syndrome (MDS) who have just received a stem cell transplant. It will involve 100 patients aged 12-65 who have a speci…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug trial aims to boost platelets in stubborn blood disorder
Disease control Not yet recruitingThis study is testing an investigational drug called golidocitinib for adults with primary immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The trial has two parts: first to find a safe dose, and then to compare the drug against a placebo to s…
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Tracking a new hope for Tough-to-Treat blood cancer patients
Disease control Not yet recruitingThis study aims to collect real-world information on how well the drug elranatamab works for Chinese patients with advanced multiple myeloma that has stopped responding to other standard treatments. It will follow about 159 patients who are already receiving this drug as part of …
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested to stop dangerous bleeding disorder
Disease control Not yet recruitingThis study aims to find the safest and most effective dose of the drug zanubrutinib when given with a steroid (dexamethasone) to adults newly diagnosed with immune thrombocytopenia (ITP). ITP is a condition where the immune system attacks platelets, increasing the risk of bruisin…
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Blood test could spare breast cancer patients from harsh chemo
Disease control Not yet recruitingThis study is testing a personalized approach to treat early-stage, hormone-sensitive breast cancer. Before surgery, patients receive a combination of targeted pills instead of standard chemotherapy. Doctors will use a simple blood test to check for cancer DNA. If the blood test …
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New hope for rare blood disorder: trial tests targeted combo therapy
Disease control Not yet recruitingThis study is testing a new combination of drugs for adults with a rare and serious blood disorder called AL amyloidosis, specifically those with a genetic marker called t(11;14). The goal is to see if adding a new drug called sonrotoclax to standard treatments can better control…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Could a shorter, gentler treatment beat a deadly blood cancer?
Disease control Not yet recruitingThis study is testing if a shorter course of a common leukemia drug combination is as effective as the standard longer course for older or frail patients. Researchers want to see if stopping the drug early for patients who respond quickly can reduce severe side effects like infec…
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
Breakthrough scan could spot lung cancer more accurately
Diagnosis Not yet recruitingThis study is testing a new type of PET scan that uses a special tracer called 68Ga-TOI-1 to detect lung cancer. Researchers want to see if this new scan can better identify cancerous lung tumors and determine how far they've spread compared to current standard PET scans. The stu…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
New 'Light-Up' tracer could sharpen cancer scans
Diagnosis Not yet recruitingThis study is testing a new imaging agent designed to make cancer cells show up more clearly on PET/CT scans. It aims to see if this tracer is safe and accurate for finding tumors in patients with common cancers like lung, breast, or colon cancer. Researchers will compare the sca…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Mar 18, 2026 14:41 UTC
-
Could your birth position prevent postpartum leaks?
Prevention Not yet recruitingThis study aims to see if the position a woman gives birth in can help prevent stress urinary incontinence (bladder leaks) after having a baby. It will follow about 670 first-time mothers, grouping them by whether they deliver lying on their back, upright, or on their side. Resea…
Sponsor: Peking University People's Hospital • Aim: Prevention
Last updated Feb 27, 2026 15:05 UTC
-
Ancient needles target modern cancer side effect
Symptom relief Not yet recruitingThis study tests whether acupuncture can safely reduce hot flashes in breast cancer patients taking hormone-blocking medications. Sixty women will receive either real or fake acupuncture three times weekly for eight weeks while continuing their standard cancer treatment. Research…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Can your Pre-Surgery walks protect your brain?
Knowledge-focused Not yet recruitingThis study aims to understand if a person's daily activity level and a protein called irisin are linked to post-surgery delirium (a temporary state of confusion) in adults 65 and older. Researchers will observe 140 patients having certain types of surgery, measuring irisin levels…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Scientists hunt for hidden blood clues to spot autoimmune diseases sooner
Knowledge-focused Not yet recruitingThis study aims to understand how different immune cells in the blood are related to disease activity in people with various autoimmune conditions. Researchers will analyze blood samples from 500 participants, including people with diseases like lupus and rheumatoid arthritis, as…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Could keeping warm during surgery ease pain after?
Knowledge-focused Not yet recruitingThis study aims to understand how a patient's body temperature during and after lung cancer surgery affects their recovery. Researchers will monitor 144 patients having minimally invasive chest surgery to see if lower temperatures lead to more complications or worse pain. The goa…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Tracking the fight for life after a stem cell transplant
Knowledge-focused Not yet recruitingThis study aims to learn what happens when patients become critically ill after a stem cell transplant. It will follow 4000 patients in China who are admitted to intensive care after their transplant. Researchers will collect detailed information on their health, treatments, and …
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC